Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BELDEN INC. Director's Dealing 2013

Apr 17, 2013

31053_dirs_2013-04-17_6f89110f-2e05-4f03-95e8-0fa01159a204.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BELDEN INC. (BDC)
CIK: 0000913142
Period of Report: 2013-04-16

Reporting Person: Trivedi Dhrupad (President, Industrial IT)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-04-16 Common Stock S 500 $46.541 Disposed 4014 Direct
2013-04-16 Common Stock S 800 $46.55 Disposed 3214 Direct
2013-04-16 Common Stock S 100 $46.5582 Disposed 3114 Direct
2013-04-16 Common Stock S 200 $46.561 Disposed 2914 Direct
2013-04-16 Common Stock S 100 $46.5644 Disposed 2814 Direct
2013-04-16 Common Stock S 35 $46.5656 Disposed 2779 Direct
2013-04-16 Common Stock M 3770 $35.83 Acquired 6549 Direct
2013-04-16 Common Stock D 3223 $46.70 Disposed 3326 Direct
2013-04-17 Common Stock S 300 $45.80 Disposed 3026 Direct
2013-04-17 Common Stock S 100 $45.8256 Disposed 2926 Direct
2013-04-17 Common Stock S 147 $45.8684 Disposed 2779 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-04-16 Stock Appreciation Rights $35.83 M 3770 Disposed 2021-03-01 Common Stock (3770) Direct

Footnotes

F1: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Trivedi on February 15, 2013.

F2: The exercise reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Trivedi on February 15, 2013.

F3: This represents the difference between the number of SARs exercised (3,770) and the number of shares issued as a result of the exercise (547). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($46.70) and the exercise price ($35.83). Additional shares are then withheld to satisfy the Company's tax withholding obligations.

F4: From the original grant of 11,310 SARs, 3,770 became exercisable on March 1, 2012, 3,770 SARs became exercisable on March 1, 2013 and 3,770 SARs will become exercisable on March 1, 2014.